Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2864-2876
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2864
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2864
Figure 3 Diagnostic performance of non-invasive parameters in differentiating grades F3-4 from F0-2 at baseline and after patients achieved sustained virologic response 12.
A: Diagnostic performance of non-invasive parameters in differentiating grades F3-4 from F0-2 at baseline; B: Diagnostic performance of non-invasive parameters in differentiating grades F3-4 from F0-2 After patients achieved sustained virologic response 12. FIB-4: Fibrosis-4; M2BPGi: Mac-2 binding protein glycosylation isomer.
- Citation: Saleh SA, Salama MM, Alhusseini MM, Mohamed GA. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World J Gastroenterol 2020; 26(21): 2864-2876
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2864.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2864